{"id":169893,"date":"2024-07-23T02:43:28","date_gmt":"2024-07-23T06:43:28","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/aligos-therapeutics-announces-clinical-collaboration-with-xiamen-amoytop-biotech-co-ltd\/"},"modified":"2024-08-18T11:48:45","modified_gmt":"2024-08-18T15:48:45","slug":"aligos-therapeutics-announces-clinical-collaboration-with-xiamen-amoytop-biotech-co-ltd","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/aligos-therapeutics-announces-clinical-collaboration-with-xiamen-amoytop-biotech-co-ltd.php","title":{"rendered":"Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd."},"content":{"rendered":"<p><![CDATA[Amoytop to sponsor a Phase 1b exploratory clinical study evaluating the efficacy and safety of ALG-000184 in combination with PEGBING\u00ae (Mipeginterferon alfa-2b) in CHB patients]]><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/22\/2916551\/0\/en\/Aligos-Therapeutics-Announces-Clinical-Collaboration-with-Xiamen-Amoytop-Biotech-Co-Ltd.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.\">Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The rest is here: Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd. <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/aligos-therapeutics-announces-clinical-collaboration-with-xiamen-amoytop-biotech-co-ltd.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-169893","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169893"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169893"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169893\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}